Key result
Gestational hypertension linked to ~10-fold higher risk of future hypertension at 5–6 years.
Cohort
Absolute Event Rate: 42.9% vs 4.1%
Primiparas with hypertension first recognized in pregnancy and an age- and parity-matched control group, normotensive throughout pregnancy, were monitored during 5-6 years with blood pressure recordings performed in a standardized way. At the end of the study period, 21 out of 49 women with hypertension in pregnancy had developed hypertension requiring therapy or borderline hypertension, compared with 2 women in the control group who had developed borderline hypertension. Therapy was required in 7 of the women. Factors associated with increased risk of developing hypertension were gestational week at diagnosis of gestational hypertension, 1st diastolic blood pressure during follow-up, family history, smoking, and age.
No takes yet. Share an insight, caveat, or question.
Lindeberg et al. (1988) conducted a cohort in Gestational hypertension. Gestational hypertension vs. Normotensive throughout pregnancy was evaluated on Development of hypertension requiring therapy or borderline hypertension. Gestational hypertension in primiparas was associated with a higher rate of future clinical or borderline hypertension at 5-6 years (42.9% vs 4.1% in matched controls).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: